Review: taking Verapamil hydrochloride and Levothyroxine thyroid together


Summary

Drug interactions are reported among people who take Verapamil hydrochloride and Levothyroxine thyroid together. This review analyzes the effectiveness and drug interactions between Verapamil hydrochloride and Levothyroxine thyroid. It is created by eHealthMe based on reports of 3,411 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Verapamil hydrochloride and Levothyroxine thyroid >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Verapamil Hydrochloride

Verapamil hydrochloride has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. (latest outcomes from Verapamil hydrochloride 3,020 users)

Levothyroxine Thyroid

Levothyroxine thyroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. (latest outcomes from Levothyroxine thyroid 742 users)

On Aug, 30, 2016

3,411 people who take Verapamil Hydrochloride, Levothyroxine Thyroid are studied.


Number of reports submitted per year:

Verapamil hydrochloride and Levothyroxine thyroid drug interactions.

Drug effectiveness over time:

Verapamil Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 30.0% - (3 of 10 people)
  • 6 - 12 months: 33.0% - (2 of 6 people)
  • 1 - 2 years: 42.0% - (3 of 7 people)
  • 2 - 5 years: 65.0% - (13 of 20 people)
  • 5 - 10 years: 64.0% - (11 of 17 people)
  • 10+ years: 90.0% - (19 of 21 people)
  • not specified: 0.0% - (0 of 1 people)
Levothyroxine Thyroid:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 57.0% - (4 of 7 people)
  • 2 - 5 years: 78.0% - (15 of 19 people)
  • 5 - 10 years: 53.0% - (8 of 15 people)
  • 10+ years: 87.0% - (28 of 32 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Verapamil Hydrochloride:
  • female: 59.0% - (39 of 66 people)
  • male: 75.0% - (12 of 16 people)
Levothyroxine Thyroid:
  • female: 67.0% - (44 of 65 people)
  • male: 86.0% - (13 of 15 people)

Drug effectiveness by age:

Verapamil Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (3 of 6 people)
  • 40-49: 53.0% - (7 of 13 people)
  • 50-59: 62.0% - (15 of 24 people)
  • 60+: 66.0% - (26 of 39 people)
Levothyroxine Thyroid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 50.0% - (3 of 6 people)
  • 40-49: 71.0% - (10 of 14 people)
  • 50-59: 65.0% - (15 of 23 people)
  • 60+: 77.0% - (28 of 36 people)

Most common drug interactions over time *:

< 1 month:
  • bradycardia
  • atrioventricular block
  • cardiogenic shock
  • hyperkalaemia
  • renal failure chronic
  • headache
  • liver disorder
  • malaise
  • reperfusion arrhythmia
  • bowel sounds abnormal
1 - 6 months:
  • dyspnoea
  • headache
  • insomnia
  • malaise
  • bursitis
  • cardiomegaly
  • cerebral haemorrhage
  • cerebrovascular accident
  • gastrointestinal haemorrhage
  • haemorrhoids
6 - 12 months:
  • anxiety
  • pain
  • cerebrovascular accident
  • deep vein thrombosis
  • hypotension
  • nausea
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood alkaline phosphatase increased
  • blood bilirubin increased
1 - 2 years:
  • synovial cyst
  • dyspnoea
  • death
  • erythema
  • nausea
  • syncope
  • anxiety
  • anxiety disorder
  • cerebrovascular accident
  • gerd
2 - 5 years:
  • pulmonary embolism
  • muscle weakness
  • therapeutic agent toxicity
  • acute sinusitis
  • bone fragmentation
  • cellulitis
  • dyspnoea
  • fatigue
  • fistula
  • gingival disorder
5 - 10 years:
  • faecaloma
  • non-hodgkin's lymphoma
  • anxiety disorder
  • breast cancer female
  • depression
  • gerd
  • headache
  • high blood pressure
  • hypothyroidism
  • migraine - classic
10+ years:
  • synovial cyst
  • bladder irritation
  • fatigue
  • anxiety
  • depression
  • nausea
  • dizziness
  • dyspnoea
  • high blood pressure
  • loss of consciousness
not specified:
  • nausea
  • dyspnoea
  • drug ineffective
  • fatigue
  • dizziness
  • pain
  • asthenia
  • chest pain
  • headache
  • back pain

Most common drug interactions by gender *:

female:
  • nausea
  • dyspnoea
  • fatigue
  • drug ineffective
  • dizziness
  • pain
  • asthenia
  • headache
  • arthralgia
  • chest pain
male:
  • dyspnoea
  • nausea
  • pain
  • atrial fibrillation
  • hypotension
  • fatigue
  • myocardial infarction
  • dizziness
  • headache
  • malaise

Most common drug interactions by age *:

0-1:
  • breech presentation
  • cardiomyopathy neonatal
  • diabetic foetopathy
  • hypoglycaemia neonatal
  • maternal drugs affecting foetus
  • pyloric stenosis
2-9:
  • abdominal pain
  • anal haemorrhage
  • asthenia
  • blood 1,25-dihydroxycholecalciferol increased
  • blood creatine increased
  • blood iron decreased
  • blood pressure fluctuation
  • dyspnoea
  • epistaxis
  • haemoglobin decreased
10-19:
  • cholecystitis chronic
  • hypothyroidism
  • vomiting
  • asthenia
  • back pain
  • chest pain
  • dysmenorrhoea
  • dyspepsia
  • dyspnoea
  • eating disorder
20-29:
  • anxiety
  • back pain
  • pain
  • asthenia
  • pain in extremity
  • palpitations
  • bronchitis
  • bursitis
  • cellulitis
  • dizziness
30-39:
  • anxiety
  • completed suicide
  • supraventricular tachycardia
  • palpitations
  • hypothyroidism
  • pyrexia
  • pain
  • anaemia
  • depression
  • dizziness
40-49:
  • nausea
  • arthralgia
  • fatigue
  • headache
  • dyspnoea
  • vomiting
  • oedema peripheral
  • gastrooesophageal reflux disease
  • pain
  • back pain
50-59:
  • dyspnoea
  • nausea
  • fatigue
  • headache
  • drug ineffective
  • arthralgia
  • anxiety
  • weight increased
  • oedema peripheral
  • chest pain
60+:
  • dyspnoea
  • nausea
  • dizziness
  • fatigue
  • drug ineffective
  • chest pain
  • diarrhoea
  • pain
  • back pain
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Verapamil hydrochloride and Levothyroxine thyroid?

Can you answer these questions?

More questions for: Verapamil hydrochloride, Levothyroxine thyroid

You may be interested in these reviews

More reviews for: Verapamil hydrochloride, Levothyroxine thyroid

On eHealthMe, Verapamil hydrochloride (verapamil hydrochloride) is often used to treat high blood pressure. Levothyroxine thyroid (levothyroxine sodium) is often used to treat hypothyroidism. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.